Ofev 100 MG capsule 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F0YD6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,095
Award facts
- Contract value 100% obligated
- $9,094.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of OFEV (Nintedanib) 100 mg capsules in a quantity of 60 units, with a ceiling value of $9,094.99 and a firm fixed price structure. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation and reflects competitively awarded procurement through open competition. Performance will be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 5, 2026.
OFEV is a specialty pharmaceutical used in the treatment of idiopathic pulmonary fibrosis, representing the type of specialized medical commodity that AmerisourceBergen supplies through its DLA contract vehicle to support military and federal healthcare systems globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order exemplifies the company's role in fulfilling federal medical supply needs for Defense Health Agency customers and other government healthcare programs through the flexible and comprehensive DLA pharmaceutical support mechanism.
Quick answers
Who was awarded contract SPE2DR26F0YD6?
SPE2DR26F0YD6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F0YD6 worth?
The government has obligated $9,095 on SPE2DR26F0YD6.
Is contract SPE2DR26F0YD6 an order under another contract?
Yes. SPE2DR26F0YD6 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0YD6 competed?
The extent of competition for SPE2DR26F0YD6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award